Li, Hongjian
Name
Li, Hongjian
Loading...
4
0
5
0
false
Results 1-3 of 3
| Issue Date | Title | Author(s) | Type | |
|---|---|---|---|---|
| 1 | Jun-2018 | Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer | Shi, Xinan ; Li, Hongjian ; Shi, Anhua ; Yao, Hong ; Ke, Kun-Bin ; Dong, Chao ; Zhu, Ying ; Qin, Yi ; Ding, Ying ; He, Yan Hong ; Liu Xu ; Li, Ling ; Lei, Ling ; Hai, Qingshan ; Chen, Wei ; Prof. LEUNG Kwong Sak ; Wong, Man-Hon ; Kung, Hsiang-Fu ; Lin, Marie, Chia-mi | Peer Reviewed Journal Article |
| 2 | 2017 | In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma | Ke, Kunbin ; Li, Hongjian ; Yao, Hong ; Shi, Xi-Nan ; Dong, Chao ; Zhu, Ying ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Wong, Man-Hon ; Liu, Xiao-Dong ; Kung, Hsiang-fu ; Lin, Marie Chia-mi | Peer Reviewed Journal Article |
| 3 | 2017 | Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells | Dong, Chao ; Yang, Runxiang ; Li, Hongjian ; Ke, Kunbin ; Luo, Chunxiang ; Yang, Fang ; Shi, Xi-Nan ; Zhu, Ying ; Liu, Xu ; Wong, Man-Hon ; Lin, Guimiao ; Wang, Xiaomei ; Prof. LEUNG Kwong Sak ; Kung, Hsiang-Fu ; Chen, Ceshi ; Lin, Marie Chia-mi | Peer Reviewed Journal Article |